{
    "clinical_study": {
        "@rank": "153063", 
        "arm_group": {
            "arm_group_label": "Physiotherapy and hypertonic saline", 
            "arm_group_type": "Experimental", 
            "description": "Chest physiotherapy integrated with inhalation of hypertonic saline"
        }, 
        "brief_summary": {
            "textblock": "Background Nebulised hypertonic saline (HS) is an established basic airway clearance\n      treatment in Cystic Fibrosis (CF). However, there is scarce evidence regarding the practical\n      implementation and administration of different HS volumes, including physiotherapy and\n      aspects of breathing pattern.\n\n      The aim of the study was to implement standardised and age-adjusted nebulised volumes of\n      hypertonic saline in cystic fibrosis patients, included in physiotherapy and lung drainage\n      techniques."
        }, 
        "brief_title": "High Volumes of Hypertonic Saline and Chest Physiotherapy in CF Patients", 
        "completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "condition": "Cystic Fibrosis", 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Fibrosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Aims: To establish a safe, efficient routine for implementation of HS in daily treatment and\n      to investigate the efficiency and tolerance of high volumes of HS integrated with chest\n      physiotherapy.\n\n      HS was given twice daily with volumes of 4,5 ml in children aged 0-5 years, 6 ml at age 6-16\n      years and 9 ml at age > 16 years. The protocol included guidance of standardized breathing\n      pattern, upright and sideways positioning and voluntary cough."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Cystic fibrosis\n\n        Exclusion Criteria:\n\n          -  Non-adherence"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943890", 
            "org_study_id": "2009/2125"
        }, 
        "intervention": [
            {
                "arm_group_label": "Physiotherapy and hypertonic saline", 
                "description": "1 mmol/ml hypertonic saline given from (small children) 1,5 ml in 3 positions twice daily increasing to (children) 2 ml in 3 positions twice daily and up to (adults) 3 ml in 3 positions twice daily", 
                "intervention_name": "Hypertonic saline", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Physiotherapy and hypertonic saline", 
                "intervention_name": "Physiotherapy", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hypertonic saline", 
            "Lung physiotherapy"
        ], 
        "lastchanged_date": "September 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bergen", 
                    "country": "Norway", 
                    "zip": "N-5021"
                }, 
                "name": "Dept. of Thoracic Medicine, Haukeland University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "1", 
        "official_title": "Establishment and Implementation of Nebulised High Volumes of Hypertonic Saline in Cystic Fibrosis Patients", 
        "overall_official": {
            "affiliation": "Dept. of Physiotherapy, Haukeland University Hospital, Bergen, Norway", 
            "last_name": "Stian Hammer", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Norway: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Tolerance and safety of high volumes of inhaled hypertonic saline measured by forced expiratory volume at one second", 
            "safety_issue": "Yes", 
            "time_frame": "24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943890"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Establishment of a standardized routine of nebulised high volumes of hypertonic saline including chest physiotherapy in cystic fibrosis patients", 
            "measure": "Implementation of nebulised high volumes of hypertonic saline in cystic fibrosis patients", 
            "safety_issue": "No", 
            "time_frame": "24 months"
        }, 
        "source": "Haukeland University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Haukeland University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2010", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}